22q11.2 Deletion Syndrome: Laboratory Diagnosis and TBX1 and FGF8 Mutation Screening

Abstract

Velocardiofacial syndrome is one of the recognized forms of chromosome 22q11.2 deletion syndrome (22q11.2 DS) and has an incidence of 1 of 4,000 to 1 of 6,000 births. Nevertheless, the 22q11 deletion is not found in several patients with a 22q11.2 DS phenotype. In this situation, other chromosomal aberrations and/or mutations in the T-box 1 transcription factor C (TBX1) gene have been detected in some patients. A similar phenotype to that of the 22q11.2 DS has been reported in animal models with mutations in fibroblast growth factor 8 (Fgf8) gene. To date, FGF8 mutations have not been investigated in humans. We tested a strategy to perform laboratory testing to reduce costs in the investigation of patients presenting with the 22q11.2 DS phenotype. A total of 109 individuals with clinical suspicion were investigated using GTG-banding karyotype, fluorescence in situ hybridization, and/or multiplex ligation-dependent probe amplification. A conclusive diagnosis was achieved in 33 of 109 (30.2%) cases. In addition, mutations in the coding regions of TBX1 and FGF8 genes were investigated in selected cases where 22q11.2 deletion had been excluded, and no pathogenic mutations were detected in both genes. This study presents a strategy for molecular genetic characterization of patients presenting with the 22q11.2 DS using different laboratory techniques. This strategy could be useful in different countries, according to local resources. Also, to our knowledge, this is the first investigation of FGF8 gene in humans with this clinical suspicion.

Keywords

velocardiofacial syndrome - 22q11.2 deletion syndrome - laboratory diagnosis - TBX1 - FGF83

• References

• 1 McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 2011; 90 (1) 1-18
• 2 Shprintzen RJ. Velo-cardio-facial syndrome: 30 Years of study. Dev Disabil Res Rev 2008; 14 (1) 3-10
• 3 Monteiro FP, Vieira TP, Sgardioli IC , et al. Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature. Eur J Pediatr 2013; 172 (7) 927-945
• 4 Oh AK, Workman LA, Wong GB. Clinical correlation of chromosome 22q11.2 fluorescent in situ hybridization analysis and velocardiofacial syndrome. Cleft Palate Craniofac J 2007; 44 (1) 62-66
• 5 Sivertsen A, Lie RT, Wilcox AJ , et al. Prevalence of duplications and deletions of the 22q11 DiGeorge syndrome region in a population-based sample of infants with cleft palate. Am J Med Genet A 2007; 143A (2) 129-134
• 6 Fernández L, Lapunzina P, Arjona D , et al. Comparative study of three diagnostic approaches (FISH, STRs and MLPA) in 30 patients with 22q11.2 deletion syndrome. Clin Genet 2005; 68 (4) 373-378
• 7 Miller DT, Adam MP, Aradhya S , et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86 (5) 749-764
• 8 Geddes GC, Butterly M, Sajan I. FISH for 22q11.2 deletion not cost effective for infants with congenital heart disease with microarray. Pediatr Cardiol 2015; 36 (3) 531-536
• 9 Jehee FS, Takamori JT, Medeiros PF , et al. Using a combination of MLPA kits to detect chromosomal imbalances in patients with multiple congenital anomalies and mental retardation is a valuable choice for developing countries. Eur J Med Genet 2011; 54 (4) e425-e432
• 10 Vieira TP, Sgardioli IC, Gil-da-Silva-Lopes VL. Genetics and public health: the experience of a reference center for diagnosis of 22q11.2 deletion in Brazil and suggestions for implementing genetic testing. J Community Genet 2013; 4 (1) 99-106
• 11 Yagi H, Furutani Y, Hamada H , et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 2003; 362 (9393) 1366-1373
• 12 Zweier C, Sticht H, Aydin-Yaylagül I, Campbell CE, Rauch A. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. Am J Hum Genet 2007; 80 (3) 510-517
• 13 Garg V, Yamagishi C, Hu T, Kathiriya IS, Yamagishi H, Srivastava D. Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development. Dev Biol 2001; 235 (1) 62-73
• 14 Zhang L, Zhong T, Wang Y, Jiang Q, Song H, Gui Y. TBX1, a DiGeorge syndrome candidate gene, is inhibited by retinoic acid. Int J Dev Biol 2006; 50 (1) 55-61
• 15 Vitelli F, Zhang Z, Huynh T, Sobotka A, Mupo A, Baldini A. Fgf8 expression in the Tbx1 domain causes skeletal abnormalities and modifies the aortic arch but not the outflow tract phenotype of Tbx1 mutants. Dev Biol 2006; 295 (2) 559-570
• 16 Hu T, Yamagishi H, Maeda J, McAnally J, Yamagishi C, Srivastava D. Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development 2004; 131 (21) 5491-5502
• 17 Frank DU, Fotheringham LK, Brewer JA , et al. An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development 2002; 129 (19) 4591-4603
• 18 Bobick BE, Thornhill TM, Kulyk WM. Fibroblast growth factors 2, 4, and 8 exert both negative and positive effects on limb, frontonasal, and mandibular chondrogenesis via MEK-ERK activation. J Cell Physiol 2007; 211 (1) 233-243
• 19 Yoshiura K, Leysens NJ, Chang J, Ward D, Murray JC, Muenke M. Genomic structure, sequence, and mapping of human FGF8 with no evidence for its role in craniosynostosis/limb defect syndromes. Am J Med Genet 1997; 72 (3) 354-362
• 20 Niswander L. Pattern formation: old models out on a limb. Nat Rev Genet 2003; 4 (2) 133-143
• 21 National Genetics Reference Laboratory Manchester, UK. MLPA spreadsheet template, 2011. Available at: http://www.ngrl.org.uk/Manchester/publications/MLPA%20Spreadsheets . Accessed January 10, 2010
• 22 Simioni M, Vieira TP, Sgardioli IC , et al. Insertional translocation of 15q25-q26 into 11p13 and duplication at 8p23.1 characterized by high resolution arrays in a boy with congenital malformations and aniridia. Am J Med Genet A 2012; 158A (11) 2905-2910
• 23 Freitas EL. Molecular biological studies in rare craniofacial anomalies. Campinas, Brazil; Universidade Estadual de Campinas: 2009
• 24 Ensembl Genome Browser database. Database of genomics sequences. Available at: http://www.ensembl.org/index.html . Accessed September 1, 2010
• 25 Fernández L, Lapunzina P, Pajares IL , et al. Unrelated chromosomal anomalies found in patients with suspected 22q11.2 deletion. Am J Med Genet A 2008; 146A (9) 1134-1141
• 26 Katzman PJ, Wang B, Sawhney M, Wang N. Differential detection of deletion 22q11.2 syndrome by specialty and indication. Pediatr Dev Pathol 2005; 8 (5) 557-567
• 27 Brunet A, Gabau E, Perich RM , et al. Microdeletion and microduplication 22q11.2 screening in 295 patients with clinical features of DiGeorge/Velocardiofacial syndrome. Am J Med Genet A 2006; 140 (22) 2426-2432
• 28 Tobias ES, Morrison N, Whiteford ML, Tolmie JL. Towards earlier diagnosis of 22q11 deletions. Arch Dis Child 1999; 81 (6) 513-514
• 29 Bartsch O, Nemecková M, Kocárek E , et al. DiGeorge/velocardiofacial syndrome: FISH studies of chromosomes 22q11 and 10p14, and clinical reports on the proximal 22q11 deletion. Am J Med Genet A 2003; 117A (1) 1-5
• 30 Greenberg F, Elder FF, Haffner P, Northrup H, Ledbetter DH. Cytogenetic findings in a prospective series of patients with DiGeorge anomaly. Am J Hum Genet 1988; 43 (5) 605-611
• 31 Tsai CH, Van Dyke DL, Feldman GL. Child with velocardiofacial syndrome and del (4)(q34.2): another critical region associated with a velocardiofacial syndrome-like phenotype. Am J Med Genet 1999; 82 (4) 336-339
• 32 Lindstrand A, Malmgren H, Verri A , et al. Molecular and clinical characterization of patients with overlapping 10p deletions. Am J Med Genet A 2010; 152A (5) 1233-1243
• 33 Smith A, St Heaps L, Robson L. Apparently unrelated cytogenetic abnormalities among 462 probands referred for the detection of del(22q) by FISH. Am J Med Genet 2002; 113 (4) 346-350
• 34 Beaujard MP, Chantot S, Dubois M , et al. Atypical deletion of 22q11.2: detection using the FISH TBX1 probe and molecular characterization with high-density SNP arrays. Eur J Med Genet 2009; 52 (5) 321-327
• 35 Jerome LA, Papaioannou VE. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 2001; 27 (3) 286-291
• 36 Gong W, Gottlieb S, Collins J , et al. Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J Med Genet 2001; 38 (12) E45